Retinoid X receptor beta polymorphisms do not explain functional differences in vitamins D and A response in Antineutrophil cytoplasmic antibody associated vasculitis patients

References

• Tidman M, Olander R, Svalander C, Danielsson D. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975–95: Organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998; 244(2)133–141
   PubMedGoogle Scholar
• Raynauld J, Bloch DA, Fries JF. Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis. J Rheumatol 1993; 20(9)1524–1526
   PubMedGoogle Scholar
• O'Donnell J, Stevanovic VR, Frampton C, Stamp LK, Chapman PT. Wegener's granulomatosis in New Zealand: Evidence for a latitude-dependent incidence gradient. Intern Med J 2007; 37(4)242–246
   PubMedGoogle Scholar
• Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gutfleisch J, Peter HH, Raspe HH, Gross WL. No difference in the incidences of vasculitides between north and south Germany: First results of the German vasculitis register. Rheumatology 2002; 41(5)540–549
   PubMedGoogle Scholar
• Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, Gross WL, Epplen JT. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 2004; 114(5)468–477
   PubMedGoogle Scholar
• Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994; 44(9)1687–1692
   PubMed Web of Science ®Google Scholar
• Al-Qadreh A, Voskaki I, Kassiou C, Athanasopoulou H, Sarafidou E, Bartsocas CS. Treatment of osteopenia in children with insulin-dependent diabetes mellitus: The effect of 1 alpha-hydroxyvitamin D3. Eur J Pediatr 1996; 155(1)15–17
   PubMedGoogle Scholar
• Hillman L, Cassidy JT, Johnson L, Lee D, Allen SH. Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis. J Pediatr 1994; 124(6)910–916
   PubMedGoogle Scholar
• Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 1992; 41(11)1491–1495
   PubMed Web of Science ®Google Scholar
• Veldman C, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000; 374(2)334–338
   PubMed Web of Science ®Google Scholar
• Takeuchi A, Reddy GS, Kobayashi T, Okano T, Park J, Sharma S. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects. J Immunol 1998; 160(1)209–218
   PubMed Web of Science ®Google Scholar
• Lemire J. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 1992; 49(1)26–31
   PubMed Web of Science ®Google Scholar
• Lemire J, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J Nutr 1995; 125(Suppl. 6)1704S–1708S
   Google Scholar
• Heine G, Niesner U, Chang HD, Steinmeyer A, Zügel U, Zuberbier T, Radbruch A, Worm M. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol 2008; 38(8)2210–2218
   PubMed Web of Science ®Google Scholar
• Falk R, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87: 4115–4119
   PubMed Web of Science ®Google Scholar
• Kälsch AI, Schmitt WH, Breedijk A, Marinaki S, Weigerding S, Nebe TC, Nemoto K, van der Woude FJ, Yard BA, Birck R. In vivo effects of cyclic administration of 15-deoxyspergualin on leucocyte function in patients with Wegener's granulomatosis. Clin Exp Immunol 2006; 146(3)455–462
   PubMed Web of Science ®Google Scholar
• Deluca H, Cantorna MT. Vitamin D: Its role and uses in immunology. FASEB 2001; 15(14)2579–2585
   PubMed Web of Science ®Google Scholar
• Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1981; 78(8)4990–4994
   PubMed Web of Science ®Google Scholar
• Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164(5)2405–2411
   PubMed Web of Science ®Google Scholar
• Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000; 164(9)4443–4451
   PubMed Web of Science ®Google Scholar
• Griffin M, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001; 98(12)6800–6805
   PubMedGoogle Scholar
• Hakim I, Bar-Shavit Z. Modulation of TNF-alpha expression in bone marrow macrophages: Involvement of vitamin D response element. J Cell Biochem 2003; 88(5)986–998
   PubMed Web of Science ®Google Scholar
• Prehn J, Fagan DL, Jordan SC, Adams JS. Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3. Blood 1992; 80(11)2811–2816
   PubMedGoogle Scholar
• Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zügel U, Steinmeyer A, Pollak A, Roth E, Boltz-Nitulescu G, Spittler A. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36(2)361–370
   PubMed Web of Science ®Google Scholar
• Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 2007; 77(1)47–57
   PubMed Web of Science ®Google Scholar
• Wang X, Allen C, Ballow M. Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPS-stimulated monocytes/macrophages. J Clin Immunol 2007; 27(2)193–200
   PubMedGoogle Scholar
• Cox S, Arthur P, Kirkwood BR, Yeboah-Antwi K, Riley EM. Vitamin A supplementation increases ratios of proinflammatory to anti-inflammatory cytokine responses in pregnancy and lactation. Clin Exp Immunol 2006; 144(3)392–400
   PubMed Web of Science ®Google Scholar
• Lamprecht P. Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 2005; 141(2)201–210
   PubMedGoogle Scholar
• Sanders J, Stegeman CA, Kallenberg CG. The Th1 and Th2 paradigm in ANCA-associated vasculitis. Kidney Blood Press Res 2003; 26: 215–220
   PubMed Web of Science ®Google Scholar